
Rochelle Bagatell
Director of CHOP’s Solid Tumor Program · University of Pennsylvania Health System
Credentials: · · · ·
History
- 1999–2000
- 1993–1996
- 1989–1993
Research
Review · The Lancet · 2007 · 1,824 citations
Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group
Journal of Clinical Oncology · 2021 · 420 citations
Journal of Clinical Oncology · 2017 · 314 citations

34 papers

34 papers

31 papers

26 papers

25 papers

22 papers

21 papers

15 papers
Grants
- 2018–2025
Tumor and Host Markers of Clinical Outcomes After MIBG Therapy in Neuroblastoma
National Cancer Institute · R01
PI · $2.5M · Dana-Farber Cancer Inst
- 2006–2012
Hsp90 as a Target for the Treatment of Childhood Cancer
National Cancer Institute · K23
Contact PI · $597K · Children's Hosp of Philadelphia
Clinical trials
- 2010
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)
- 2010–2013
Study of EZN-2208 Pediatric Patients With Solid Tumors
Study chair · Terminated · Phase 1, Phase 2
Enzon Pharmaceuticals, Inc.
- 2006–2013
Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
Study chair · Completed · Phase 2
Children's Oncology Group
- 2024–2029
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)


